ABL1 and myeloproliferative neoplasm: The screening of BCR-ABL transcripts performed to differentiate BCR-ABL positive or negative MPN patients confirmed that all investigated 105 MPN patients were BCR-ABL transcripts negative (Philadelphia chromosome negative).